Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Holmgren

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxinCarmelo Luci, Catherine Hervouet, Déborah Rousseau, et al.
Vaccine|August 19, 2018
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvantJan Holmgren, Stefan Nordqvist, Margareta Blomquist, et al.
Microbial Pathogenesis|November 19, 2013
Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditionsMayra Cobaxin, Haydee Martínez, Guadalupe Ayala, et al.
Lancet (London, England)|March 18, 2017
CholeraJohn D Clemens, G Balakrish Nair, Tahmeed Ahmed, et al.
Infection and Immunity|February 27, 2013
A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infectionLouise Sjökvist Ottsjö, Carl-Fredrik Flach, John Clements, et al.
Microbial Pathogenesis|February 21, 2017
Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigensJoshua Tobias, Michael Lebens, Sun Nyunt Wai, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 4, 2016
Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrheaAnnika Borde, Annelie Ekman, Anette Larsson, et al.
Parasite Immunology|October 31, 2002
Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-beta production by CD4 T cellsHector J Hernandez, Laura I Rutitzky, Mike Lebens, et al.
Immunology|June 6, 2002
Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivoHamid Sadeghi, Søren Bregenholt, Dale Wegmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responsesFabienne Anjuère, Annie George-Chandy, Florence Audant, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxinCarmelo Luci, Catherine Hervouet, Déborah Rousseau, et al.
Vaccine|August 19, 2018
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvantJan Holmgren, Stefan Nordqvist, Margareta Blomquist, et al.
Microbial Pathogenesis|November 19, 2013
Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditionsMayra Cobaxin, Haydee Martínez, Guadalupe Ayala, et al.
Lancet (London, England)|March 18, 2017
CholeraJohn D Clemens, G Balakrish Nair, Tahmeed Ahmed, et al.
Infection and Immunity|February 27, 2013
A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infectionLouise Sjökvist Ottsjö, Carl-Fredrik Flach, John Clements, et al.
Microbial Pathogenesis|February 21, 2017
Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigensJoshua Tobias, Michael Lebens, Sun Nyunt Wai, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 4, 2016
Preparation and preclinical evaluation of a freeze-dried formulation of a novel combined multivalent whole-cell/B-subunit oral vaccine against enterotoxigenic Escherichia coli diarrheaAnnika Borde, Annelie Ekman, Anette Larsson, et al.
Parasite Immunology|October 31, 2002
Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-beta production by CD4 T cellsHector J Hernandez, Laura I Rutitzky, Mike Lebens, et al.
Immunology|June 6, 2002
Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivoHamid Sadeghi, Søren Bregenholt, Dale Wegmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responsesFabienne Anjuère, Annie George-Chandy, Florence Audant, et al.
Pageof 13